AlphaYouBR
Fund 13F filing
BlackRock cut $76.4M of KalVista Pharmaceuticals, Inc. (KALV) stock
BlackRock cut $76.4M of KalVista Pharmaceuticals, Inc. (KALV) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 7, 2026.
A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.
- Disclosed
- Aug 7, 2026
- Quarter end
- Jun 30, 2026
- Source
- SEC Form 13F
More KALV insider and Congress trades
From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.